MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 4.325
AS - Asia 1.842
EU - Europa 1.378
SA - Sud America 279
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.873
Nazione #
US - Stati Uniti d'America 4.212
SG - Singapore 607
CN - Cina 454
IT - Italia 379
VN - Vietnam 251
DE - Germania 237
BR - Brasile 218
PL - Polonia 170
HK - Hong Kong 133
FI - Finlandia 125
GB - Regno Unito 116
BD - Bangladesh 109
UA - Ucraina 97
TR - Turchia 87
CA - Canada 64
FR - Francia 61
JP - Giappone 52
SE - Svezia 48
RU - Federazione Russa 44
IN - India 35
MX - Messico 30
NL - Olanda 30
ID - Indonesia 29
AR - Argentina 23
BE - Belgio 17
PK - Pakistan 14
IQ - Iraq 12
ZA - Sudafrica 11
ES - Italia 10
LT - Lituania 10
EC - Ecuador 9
IE - Irlanda 9
TN - Tunisia 9
MY - Malesia 8
UZ - Uzbekistan 8
VE - Venezuela 8
MA - Marocco 7
CO - Colombia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CZ - Repubblica Ceca 5
JM - Giamaica 4
KR - Corea 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CH - Svizzera 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.872
Città #
Dallas 813
Ashburn 514
Singapore 379
San Jose 265
Fairfield 264
Woodbridge 232
Ann Arbor 192
Warsaw 168
Beijing 158
Houston 150
Chandler 142
Santa Clara 138
Seattle 137
Munich 129
Hong Kong 122
Wilmington 119
Jacksonville 115
Ferrara 102
New York 96
Cambridge 92
Helsinki 79
Ho Chi Minh City 72
Los Angeles 72
Hanoi 50
Tokyo 50
Council Bluffs 49
Izmir 43
Nanjing 40
Milan 37
Dong Ket 34
Lauterbourg 31
Princeton 28
Shanghai 27
Bologna 26
São Paulo 26
The Dalles 25
Boardman 23
Dearborn 20
Jakarta 19
Toronto 18
Brussels 17
Chicago 17
Brooklyn 16
Buffalo 16
Mexico City 16
Fuzhou 15
Mcallen 14
San Diego 14
Montreal 13
Montréal 13
Padova 13
Amsterdam 12
Frankfurt am Main 12
Moscow 12
Phoenix 12
Turku 12
Atlanta 11
Da Nang 11
London 11
Denver 10
Haiphong 10
Nanchang 10
Orem 10
Rio de Janeiro 10
Stockholm 10
Boston 9
Dublin 9
Hefei 9
Poplar 9
Columbus 8
Florence 8
Lahore 8
Rome 8
Tashkent 8
Chennai 7
Falls Church 7
Bremen 6
Changsha 6
Dhaka 6
Jiaxing 6
Johannesburg 6
Nuremberg 6
Auburn Hills 5
Baghdad 5
Brasília 5
Jyväskylä 5
Kuala Lumpur 5
Lappeenranta 5
Manchester 5
Mumbai 5
Naples 5
Padua 5
Philadelphia 5
San Francisco 5
Shenyang 5
Tianjin 5
Addison 4
Ankara 4
Augusta 4
Bari 4
Totale 5.625
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 996
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 378
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 376
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 302
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 290
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 265
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 252
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 234
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 231
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 227
Pharmacological characterization of tachykinin tetrabranched derivatives 218
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 215
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 213
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 206
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 205
null 205
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 205
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 203
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 195
NOP receptor pharmacological profile – A dynamic mass redistribution study 183
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 182
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 180
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 179
Pharmacological Assays for Investigating the NOP Receptor 175
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 153
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment 151
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 142
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 142
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 140
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 116
Pharmacological characterization of naloxegol: In vitro and in vivo studies 114
null 110
null 105
null 103
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 95
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 86
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 69
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 34
Comprehensive transduceromic profiling of NOP receptor ligands at different Gα subunits 17
Totale 7.970
Categoria #
all - tutte 30.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 999
Totale 31.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022265 24 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024288 18 23 5 7 14 58 14 57 3 9 17 63
2024/20251.048 29 39 80 32 91 123 80 70 172 89 138 105
2025/20263.736 317 286 819 362 395 217 344 173 240 301 152 130
2026/2027101 101 0 0 0 0 0 0 0 0 0 0 0
Totale 7.970